RxDoctor Payments Data

Christine White

Psychiatry · Princeton, MENPI 1336124114

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 94.5% of the total across 90 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Lundbeck LLC at 31.5% of the total. 2025 is the largest year on record at $458, 2.7 times the $171 reported in 2019. Among psychiatry clinicians in ME with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,723in general payments, 2019–2025

Across 90 payments — averaging $19.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lundbeck LLC$542
  • Novo Nordisk$263
  • Otsuka America Pharmaceutical, Inc.$215
  • Johnson & Johnson$102
  • Alkermes, Inc.$81
  • Teva Pharmaceuticals USA, Inc.$75
  • plus $443 from 13 others

What the payments were for

  • Food & beverage$1,62894%
  • Education$815%
  • Other$141%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,723 in reported general payments places this provider in the 95th percentile of 167 psychiatry providers in Maine.

See all psychiatry providers in Maine

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate16$54,637
TrintellixVortioxetine Hydrobromide31$21,314
VyvanseLisdexamfetamine Dimesylate21$12,405
Lurasidone Hcl16$12,326
Modafinil18$10,136
Aripiprazole41$3,693
Venlafaxine Hcl ErVenlafaxine Hcl36$3,597
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine26$2,494
Clozapine19$2,398
Quetiapine Fumarate107$1,857
Hydroxyzine Hcl55$1,519
Duloxetine Hcl54$1,185
Bupropion XlBupropion Hcl28$893
Trazodone Hcl74$812
Gabapentin50$779

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$102$54,63716 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse$36$33,71952 claims
Lilly USA, LLCOlanzapine$18$28916 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 167 psychiatry providers in Maine.

Other psychiatry in Princeton

See the full list for Maine

Where these figures come from

Is this you, or does something look wrong? →